🇺🇸 FDA
Patent

US 8071074

Preventing airway mucus production by administration of EGF-R antagonists

granted A61KA61K31/00A61P

Quick answer

US patent 8071074 (Preventing airway mucus production by administration of EGF-R antagonists) held by The Regents of the University of California expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/00, A61P, A61P11/00, A61P11/02